Guidelines for Cryopreservation of Blood Cells

Erythrocyte components (EC) and platelet concentrates (TC) are in demand for the treatment of patients with anemia and thrombocytopenia, developing against a background of massive blood loss in polytrauma, as well as after chemo- and radiotherapy. At present in the USA 1.5 million TC transfusions are performed annually, and in European countries - 2.9 million. In the Russian Federation about 500 thousand TC are procured annually, at that EC are in greater demand. In 2012 about 2 mln. doses of EC were stocked in the Russian Federation. The deficit was about 1.4 mln doses. The Russian Federation is witnessing the growth of preserved red blood cells harvesting from 43139 doses in 2002 to 48808 doses in 2013.